These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9127169)

  • 21. [Effect of octreotide on the clinical course of acute pancreatitis and levels of free oxygen radicals and antioxidants].
    Lata J; Dítĕ P; Julínková K; Precechtĕlová M; Prásek J
    Vnitr Lek; 1998 Sep; 44(9):524-7. PubMed ID: 10358462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy.
    Arcidiacono R; Gambitta P; Rossi A; Grosso C; Bini M; Zanasi G
    Endoscopy; 1994 Nov; 26(9):715-8. PubMed ID: 7536155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Octreotide treatment in patients with severe acute pancreatitis.
    Paran H; Mayo A; Paran D; Neufeld D; Shwartz I; Zissin R; Singer P; Kaplan O; Skornik Y; Freund U
    Dig Dis Sci; 2000 Nov; 45(11):2247-51. PubMed ID: 11215748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.
    Sternlieb JM; Aronchick CA; Retig JN; Dabezies M; Saunders F; Goosenberg E; Infantolino A; Ionna S; Maislin G; Wright SH
    Am J Gastroenterol; 1992 Nov; 87(11):1561-6. PubMed ID: 1279967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?
    Binmoeller KF; Harris AG; Dumas R; Grimaldi C; Delmont JP
    Gut; 1992 Aug; 33(8):1129-33. PubMed ID: 1383099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective placebo-controlled randomized trial of lexipafant in predicted severe acute pancreatitis.
    McKay CJ; Curran F; Sharples C; Baxter JN; Imrie CW
    Br J Surg; 1997 Sep; 84(9):1239-43. PubMed ID: 9313702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current diagnosis and treatment of acute pancreatitis in China: a real-world, multicenter study.
    Sun C; Li Z; Shi Z; Li G
    BMC Gastroenterol; 2021 May; 21(1):210. PubMed ID: 33964868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Octreotide: effects in experimental severe acute pancreatitis. Analysis of survival, biochemical findings and histomorphometry.
    Sánchez Manuel J; Landa García JI; Seco Gil JL; Velasco Oses A; Coma del Corral MJ; Vaquero Puerta C; Santamaría García JL
    Rev Esp Enferm Dig; 1997 Feb; 89(2):101-15. PubMed ID: 9115817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conservative treatment of acute pancreatitis: the use of somatostatin.
    Ladas SD; Raptis SA
    Hepatogastroenterology; 1992 Oct; 39(5):466-9. PubMed ID: 1360937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of the somatostatin analogue octreotide in ischemia/reperfusion-induced acute pancreatitis in rats.
    Hoffmann TF; Uhl E; Messmer K
    Pancreas; 1996 Apr; 12(3):286-93. PubMed ID: 8830336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological interventions for acute pancreatitis.
    Moggia E; Koti R; Belgaumkar AP; Fazio F; Pereira SP; Davidson BR; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011384. PubMed ID: 28431202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis.
    Andriulli A; Leandro G; Clemente R; Festa V; Caruso N; Annese V; Lezzi G; Lichino E; Bruno F; Perri F
    Aliment Pharmacol Ther; 1998 Mar; 12(3):237-45. PubMed ID: 9570258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extensive hemorrhagic erosive gastritis associated with acute pancreatitis successfully treated with a somatostatin analog.
    Yabuki K; Maekawa T; Satoh K; Tamasaki Y; Maekawa H; Kudoh K; Aoki E
    J Gastroenterol; 2002; 37(9):737-41. PubMed ID: 12375148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High dose octreotide in the management of acute pancreatitis.
    Karakoyunlar O; Sivrel E; Tanir N; Deneçli AG
    Hepatogastroenterology; 1999; 46(27):1968-72. PubMed ID: 10430379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial.
    Testoni PA; Bagnolo F; Andriulli A; Bernasconi G; Crotta S; Lella F; Lomazzi A; Minoli G; Natale C; Prada A; Toti GL; Zambelli A
    Aliment Pharmacol Ther; 2001 Jul; 15(7):965-72. PubMed ID: 11421871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-acting octreotide versus placebo for treatment of advanced HCC: a randomized controlled double-blind study.
    Becker G; Allgaier HP; Olschewski M; Zähringer A; Blum HE;
    Hepatology; 2007 Jan; 45(1):9-15. PubMed ID: 17187405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial.
    Caroli A; Perico N; Perna A; Antiga L; Brambilla P; Pisani A; Visciano B; Imbriaco M; Messa P; Cerutti R; Dugo M; Cancian L; Buongiorno E; De Pascalis A; Gaspari F; Carrara F; Rubis N; Prandini S; Remuzzi A; Remuzzi G; Ruggenenti P;
    Lancet; 2013 Nov; 382(9903):1485-95. PubMed ID: 23972263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP.
    Arvanitidis D; Hatzipanayiotis J; Koutsounopoulos G; Frangou E
    Hepatogastroenterology; 1998; 45(19):248-52. PubMed ID: 9496522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical use of the long acting somatostatin analogue octreotide in pediatrics.
    Tauber MT; Harris AG; Rochiccioli P
    Eur J Pediatr; 1994 May; 153(5):304-10. PubMed ID: 8033916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis.
    Friess H; Beger HG; Sulkowski U; Becker H; Hofbauer B; Dennler HJ; Büchler MW
    Br J Surg; 1995 Sep; 82(9):1270-3. PubMed ID: 7552016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.